NCT03203512View on ClinicalTrials.gov

Fish Oil-derived N-3 Polyunsaturated Fatty Acids and Extracellular Vesicles

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 16, 2018

Primary Completion Date

November 30, 2019

Study Completion Date

March 30, 2021

Conditions
Extracellular Vesicles; Generation and Function
Interventions
DIETARY_SUPPLEMENT

Fish oil capsules

Each serving contains 360mg eicosapentaenoic acid (EPA), 270mg docosahexaenoic acid (DHA) and total supplement is 1.8 g per day n-3 PUFA for 12 weeks

DIETARY_SUPPLEMENT

High-oleic safflower oil capsules

High-oleic safflower oil capsules for 12 weeks

Trial Locations (1)

RG6 6AP

University of Reading, Reading

All Listed Sponsors
collaborator

Biotechnology and Biological Sciences Research Council

OTHER

lead

University of Reading

OTHER

NCT03203512 - Fish Oil-derived N-3 Polyunsaturated Fatty Acids and Extracellular Vesicles | Biotech Hunter | Biotech Hunter